Comparison of the diagnostic efficacy of 68 Ga-FAPI-04 PET/MR and 18F-FDG PET/CT in patients with pancreatic cancer

[1]  X. Lan,et al.  68Ga-DOTA-FAPI-04 PET/MR in the Evaluation of Gastric Carcinomas: Comparison with 18F-FDG PET/CT , 2021, The Journal of Nuclear Medicine.

[2]  X. Lan,et al.  A head-to-head comparison of 68Ga-DOTA-FAPI-04 and 18F-FDG PET/MR in patients with nasopharyngeal carcinoma: a prospective study , 2021, European Journal of Nuclear Medicine and Molecular Imaging.

[3]  J. Choi,et al.  Impact of F-18 Fluorodeoxyglucose PET/CT and PET/MRI on Initial Staging and Changes in Management of Pancreatic Ductal Adenocarcinoma: A Systemic Review and Meta-Analysis , 2020, Diagnostics.

[4]  D. Jäger,et al.  Impact of 68Ga-FAPI PET/CT Imaging on the Therapeutic Management of Primary and Recurrent Pancreatic Ductal Adenocarcinomas , 2020, The Journal of Nuclear Medicine.

[5]  Wen Zhang,et al.  Fibroblast Activation Protein–Targeted PET/CT with 68Ga-FAPI for Imaging IgG4-Related Disease: Comparison to 18F-FDG PET/CT , 2020, The Journal of Nuclear Medicine.

[6]  Hua Wu,et al.  Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer , 2020, European Journal of Nuclear Medicine and Molecular Imaging.

[7]  V. Weaver,et al.  The fibrotic tumor stroma. , 2020, Biochimica et biophysica acta. Reviews on cancer.

[8]  A. Jemal,et al.  Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.

[9]  Z. Pan,et al.  Immune Cell Infiltration in the Microenvironment of Liver Oligometastasis from Colorectal Cancer: Intratumoural CD8/CD3 Ratio Is a Valuable Prognostic Index for Patients Undergoing Liver Metastasectomy , 2019, Cancers.

[10]  R. Zárate,et al.  Omics Approaches in Pancreatic Adenocarcinoma , 2019, Cancers.

[11]  S. Hingorani,et al.  Fibroblasts in Pancreatic Ductal Adenocarcinoma: Biological Mechanisms and Therapeutic Targets. , 2019, Gastroenterology.

[12]  H. Kauczor,et al.  68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer , 2019, The Journal of Nuclear Medicine.

[13]  Thomas Lindner,et al.  Development of Fibroblast Activation Protein–Targeted Radiotracers with Improved Tumor Retention , 2019, The Journal of Nuclear Medicine.

[14]  S. Detlefsen,et al.  Typing of pancreatic cancer-associated fibroblasts identifies different subpopulations , 2018, World journal of gastroenterology.

[15]  D. Tuveson,et al.  Stromal biology and therapy in pancreatic cancer: ready for clinical translation? , 2018, Gut.

[16]  Thomas Lindner,et al.  Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein , 2018, The Journal of Nuclear Medicine.

[17]  Frederik L. Giesel,et al.  68Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers , 2018, The Journal of Nuclear Medicine.

[18]  D. Hough,et al.  The Role of 18F-FDG PET/CT and PET/MRI in Pancreatic Ductal Adenocarcinoma , 2018, Abdominal Radiology.

[19]  K. Książek,et al.  The peritoneal “soil” for a cancerous “seed”: a comprehensive review of the pathogenesis of intraperitoneal cancer metastases , 2017, Cellular and Molecular Life Sciences.

[20]  H. Honda,et al.  Multiparametric voxel-based analyses of standardized uptake values and apparent diffusion coefficients of soft-tissue tumours with a positron emission tomography/magnetic resonance system: Preliminary results , 2017, European Radiology.

[21]  A. Maitra,et al.  The role of stromal cancer-associated fibroblasts in pancreatic cancer , 2017, Journal of Hematology & Oncology.

[22]  Yuli Lin,et al.  FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3-CCL2 Signaling. , 2016, Cancer research.

[23]  T. Geiger,et al.  Tumor-derived osteopontin reprograms normal mammary fibroblasts to promote inflammation and tumor growth in breast cancer. , 2015, Cancer research.

[24]  Chen Jin,et al.  Utility of PET/CT in diagnosis, staging, assessment of resectability and metabolic response of pancreatic cancer. , 2014, World journal of gastroenterology.

[25]  H. Duivenvoorden,et al.  Usefulness of F-18-fluorodeoxyglucose positron emission tomography to confirm suspected pancreatic cancer: a meta-analysis. , 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[26]  Alexander A. Fingerle,et al.  The role of stroma in pancreatic cancer: diagnostic and therapeutic implications , 2012, Nature Reviews Gastroenterology &Hepatology.

[27]  T. Murakami,et al.  Overestimating the size of hepatic malignancy on helical CT during arterial portography: equilibrium phase CT and pathology. , 1997, Journal of computer assisted tomography.

[28]  J. Kleeff,et al.  Pancreatic cancer , 1988, Nature Reviews Disease Primers.

[29]  J. Kleeff,et al.  Chronic pancreatitis , 2017, Nature Reviews Disease Primers.

[30]  Wang-Sheng Chen,et al.  Comparison of MRI, CT and 18F-FDG PET/CT in the diagnosis of local and metastatic of nasopharyngeal carcinomas: an updated meta analysis of clinical studies. , 2016, American journal of translational research.

[31]  Irina Rinta-Kiikka,et al.  F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography, Multidetector Row Computed Tomography, and Magnetic Resonance Imaging in Primary Diagnosis and Staging of Pancreatic Cancer , 2009 .

[32]  金子 文成,et al.  長時間歩行時の下肢筋の活動状態:[ 18 F]fluorodeoxyglucoseを用いたPositron Emission Tomographyによる検討 , 2008 .